"Kadlec’s Outpatient Imaging Center includes some of the most advanced imaging technologies available. We have an all-digital format that provides physicians with imaging results quickly to diagnose and treat patients fast."

During the past decade, Outpatient Imaging Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Outpatient Imaging Center" are "Metastatic Colorectal Cancer" (1 trials), "Metastatic Colorectal Carcinoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Outpatient Imaging Center" in a lesser frequency.

Most popular intervention types in "Outpatient Imaging Center" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-05212384" (2 trials), "Active Comparator (erlotinib)" (1 trials), "Bevacizumab" (1 trials), "Cetuximab" (1 trials) and "Dacomitinib (PF-00299804)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Outpatient Imaging Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Outpatient Imaging Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Outpatient Imaging Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Outpatient Imaging Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".